Literature DB >> 20452301

Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.

Laura Stronati1, Anna Negroni, Maria Pierdomenico, Chiara D'Ottavio, Donatella Tirindelli, Giovanni Di Nardo, Salvatore Oliva, Franca Viola, Salvatore Cucchiara.   

Abstract

BACKGROUND: Innate immunity has been very rarely investigated in ulcerative colitis and never in paediatrics. The present study was aimed at describing expression of innate immunity genes (NOD2, RIP2, α-defensins HD5 and HD6) in inflamed colon and in ileum of children with ulcerative colitis. Expression of TNFα and IL-1β was also analyzed.
METHODS: 15 children with ulcerative colitis (9 pancolitis, 6 left-sided colitis) and 10 control children were enrolled. mRNA and protein expressions were detected by real time PCR and western blot assays.
RESULTS: NOD2, RIP2, IL-1β, TNFα expression levels were significantly increased in colonic mucosa of patients compared to controls (p<0.01). These genes were also upregulated (p<0.01) in the ileum of both pancolitis and left-sided colitis children. HD5 and HD6 were significantly upregulated (p<0.01) in the inflamed colon of patients as well as in the ileum of those with pancolitis.
CONCLUSIONS: An increased mucosal expression of innate immunity genes was found in the inflamed colon of children with ulcerative colitis, outlining the role of the innate immune response in disease pathogenesis. Involvement of the ileum in ulcerative colitis suggests that an immune activation can also be established in intestinal sites classically uninvolved by the inflammation, carrying implications for the treatment and course of the disease.
Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452301     DOI: 10.1016/j.dld.2010.04.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

1.  Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors.

Authors:  Curt D Haffner; Adam K Charnley; Christopher J Aquino; Linda Casillas; Máire A Convery; Julie A Cox; Mark A Elban; Nicole C Goodwin; Peter J Gough; Pamela A Haile; Terry V Hughes; Beth Knapp-Reed; Constantine Kreatsoulas; Ami S Lakdawala; Huijie Li; Yiqian Lian; David Lipshutz; John F Mehlmann; Michael Ouellette; Joseph Romano; Lisa Shewchuk; Arthur Shu; Bartholomew J Votta; Huiqiang Zhou; John Bertin; Robert W Marquis
Journal:  ACS Med Chem Lett       Date:  2019-10-11       Impact factor: 4.345

2.  IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.

Authors:  Elena Voronov; Ron N Apte
Journal:  Cancer Microenviron       Date:  2015-12-19

Review 3.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

Review 4.  Kinases on Double Duty: A Review of UniProtKB Annotated Bifunctionality within the Kinome.

Authors:  Aziz M Rangwala; Victoria R Mingione; George Georghiou; Markus A Seeliger
Journal:  Biomolecules       Date:  2022-05-11

Review 5.  Targeting RIP Kinases in Chronic Inflammatory Disease.

Authors:  Mary Speir; Tirta M Djajawi; Stephanie A Conos; Hazel Tye; Kate E Lawlor
Journal:  Biomolecules       Date:  2021-04-28

Review 6.  Enteric alpha defensins in norm and pathology.

Authors:  Nikolai A Lisitsyn; Yulia A Bukurova; Inna G Nikitina; George S Krasnov; Yuri Sykulev; Sergey F Beresten
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-01-11       Impact factor: 3.944

Review 7.  Role of TLR4  rs4986790A>G and rs4986791C>T Polymorphisms in the Risk of Inflammatory Bowel Disease.

Authors:  Ran Ao; Ying Wang; Dao-Rong Zhnag; Ya-Qi Du
Journal:  Gastroenterol Res Pract       Date:  2015-05-18       Impact factor: 2.260

Review 8.  NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.

Authors:  Patricia Ahechu; Gabriel Zozaya; Pablo Martí; José Luis Hernández-Lizoáin; Jorge Baixauli; Xabier Unamuno; Gema Frühbeck; Victoria Catalán
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

9.  Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.

Authors:  Rola F Jaafar; Zeid Ibrahim; Karim Ataya; Joelle Hassanieh; Natasha Ard; Walid Faraj
Journal:  Medicina (Kaunas)       Date:  2021-07-14       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.